A letter was sent to senators on Tuesday by a group of doctors, drugmakers and public health organizations asking lawmakers to establish policies that would encourage antimicrobial drug development. "[T]he future of antibiotic development is grim. … Few major pharmaceutical companies remain engaged in antibiotic discovery and development, and small biotech firms, even those that have launched or are close to launching products, struggle to sustain a viable commercial enterprise," the letter said.
Groups push for policy development to encourage antibiotic approvals
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.